CVS Health (CVS) Price Target Boosted by $8 at Mizuho

May 24, 2026 - 18:05

Mizuho analysts raised their price target on CVS Health shares by $8 on May 20, signaling confidence in the company's ongoing turnaround efforts. The new target reflects expectations that CVS will benefit from stronger performance in its health services segment and improved margins in its insurance business.

CVS Health Corporation, a major player in the U.S. healthcare system, operates through pharmacy services, health plans, and retail health clinics. The company has been working to integrate its Aetna insurance unit with its pharmacy and clinic operations to deliver more coordinated care. Mizuho's upgrade suggests that these integration efforts are starting to pay off.

The stock also appeals to income-focused investors. CVS currently offers an annual dividend yield of roughly 2.84%, making it one of the more attractive payout stocks in the healthcare sector. The company has a long track record of increasing its dividend, which adds to its appeal for those seeking reliable income.

Despite headwinds like rising medical costs and regulatory pressure on pharmacy benefit managers, CVS has maintained its focus on cost control and operational efficiency. The revised price target from Mizuho indicates that Wall Street sees potential for further upside as the company navigates these challenges.

Shares of CVS have fluctuated over the past year as investors weigh the risks and rewards of its transformation strategy. With the new price target, analysts are signaling that the risk-reward balance may be tipping in favor of the bulls.